Laboratory of Ontogeny and Reproduction, CHUQ, CHUL, Laval University, Quebec City, Quebec, Canada.
Reprod Biol Endocrinol. 2010 Jan 8;8:2. doi: 10.1186/1477-7827-8-2.
Accumulating evidences suggest that sex affects lung development. Indeed, a higher incidence of respiratory distress syndrome is observed in male compared to female preterm neonates at comparable developmental stage and experimental studies demonstrated an androgen-related delay in male lung maturation. However, the precise mechanisms underlying these deleterious effects of androgens in lung maturation are only partially understood.
To build up a better understanding of the effect of androgens on lung development, we analyzed by microarrays the expression of genes showing a sexual difference and those modulated by androgens. Lungs of murine fetuses resulting from a timely mating window of 1 hour were studied at gestational day 17 (GD17) and GD18, corresponding to the period of surge of surfactant production. Using injections of the antiandrogen flutamide to pregnant mice, we hunted for genes in fetal lungs which are transcriptionally modulated by androgens.
Results revealed that 1844 genes were expressed with a sexual difference at GD17 and 833 at GD18. Many genes were significantly modulated by flutamide: 1597 at GD17 and 1775 at GD18. Datasets were analyzed by using in silico tools for reconstruction of cellular pathways. Between GD17 and GD18, male lungs showed an intensive transcriptional activity of proliferative pathways along with the onset of lung differentiation. Among the genes showing a sex difference or an antiandrogen modulation of their expression, we specifically identified androgen receptor interacting genes, surfactant related genes in particularly those involved in the pathway leading to phospholipid synthesis, and several genes of lung development regulator pathways. Among these latter, some genes related to Shh, FGF, TGF-beta, BMP, and Wnt signaling are modulated by sex and/or antiandrogen treatment.
Our results show clearly that there is a real delay in lung maturation between male and female in this period, the latter pursuing already lung maturation while the proper is not yet fully engaged in the differentiation processes at GD17. In addition, this study provides a list of genes which are under the control of androgens within the lung at the moment of surge of surfactant production in murine fetal lung.
越来越多的证据表明,性别会影响肺部发育。事实上,在相同发育阶段的早产儿中,男性比女性患呼吸窘迫综合征的发病率更高,实验研究表明雄激素会导致男性肺成熟延迟。然而,雄激素对肺成熟产生这些有害影响的确切机制尚不完全清楚。
为了更好地了解雄激素对肺发育的影响,我们通过微阵列分析了显示性别差异和受雄激素调节的基因的表达。在妊娠第 17 天(GD17)和第 18 天(GD18)研究了在 1 小时的适时交配窗口后产生的胎鼠肺部,这两个时间点分别对应于表面活性剂产生的激增期。我们通过向怀孕的老鼠注射抗雄激素氟他胺,来寻找在胎儿肺部中受雄激素转录调控的基因。
结果显示,17 天龄的胎鼠中有 1844 个基因具有性别差异表达,18 天龄时有 833 个基因具有性别差异表达。许多基因的表达受到氟他胺的显著调节:17 天龄时有 1597 个,18 天龄时有 1775 个。数据集通过使用计算机工具进行细胞通路重建进行了分析。在 GD17 和 GD18 之间,雄性肺部显示出增殖途径的强烈转录活性,同时伴随着肺分化的开始。在具有性别差异或雄激素调节其表达的基因中,我们特别鉴定了雄激素受体相互作用基因、表面活性剂相关基因,特别是参与磷脂合成途径的基因,以及几个肺发育调控途径的基因。其中,一些与 Shh、FGF、TGF-β、BMP 和 Wnt 信号相关的基因受到性别和/或抗雄激素处理的调节。
我们的研究结果清楚地表明,在这个时期,雄性和雌性之间的肺成熟确实存在延迟,后者已经在进行肺成熟,而前者尚未完全参与 GD17 时的分化过程。此外,这项研究提供了在胎鼠肺部表面活性剂产生激增时,肺部中受雄激素控制的基因列表。